Related Experiment Video
Updated: Jan 30, 2026
07:20
Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
Published on: April 9, 2019
9.7K
Radiosynovectomy in haemophilia
1Department of Orthopaedic Surgery, "La Paz" University Hospital-IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain.
Blood Reviews
|February 2, 2019
Summary
Radiosynovectomy (RS) offers a safe and effective treatment for hemophilic synovitis, providing relief from recurrent joint bleeding. This minimally invasive procedure is a cost-effective first option over surgery for managing chronic synovitis in hemophilia patients.
Area of Science:
- Orthopedics
- Radiology
- Hematology
Background:
- Hemophilic synovitis causes repetitive hemarthrosis, impacting joint health.
- Chronic synovitis in hemophilia often requires invasive treatment.
- Current treatments may not be sufficiently effective or cost-efficient.
Purpose of the Study:
- To evaluate the efficacy and safety of radiosynovectomy (RS) for hemophilic synovitis.
- To establish RS as a primary invasive treatment option for chronic synovitis.
- To compare the cost-effectiveness of RS versus arthroscopic synovectomy.
Main Methods:
- Clinical confirmation of synovitis (palpable mass).
- Ultrasonography to confirm synovitis in joints with recurrent hemarthrosis.
- RS performed under factor coverage for hemophilic patients.
Main Results:
- Radiosynovectomy is a simple, effective, and safe procedure.
- RS is more cost-effective than arthroscopic synovectomy.
- No increased cancer risk reported with minimal radiation dose.
Conclusions:
- RS is the preferred first invasive option for chronic hemophilic synovitis.
- RS is a valuable adjunctive procedure to intensive replacement therapy.
- Early RS confirmation via ultrasonography is crucial for treatment.
